GF Fund Management’s Boston Scientific BSX Stock Holding History

GF Fund Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.76M	Buy	41,184 +435	+1%	+$23.6K	0.02%	162
2026 Q1	$2.56M	Hold	40,749	–	–	0.04%	157
2025 Q4	$3.89M	Sell	40,749 -769	-2%	-$75.4K	0.07%	150
2025 Q3	$4.05M	Buy	41,518 +10,498	+34%	+$1.09M	0.07%	152
2025 Q2	$3.33M	Sell	31,020 -232	-0.7%	-$23.5K	0.07%	164
2025 Q1	$3.15M	Hold	31,252	–	–	0.07%	159
2024 Q4	$2.79M	Buy	+31,252	New	+$2.75M	0.06%	163

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GF Fund Management's BSX Position: Q2 2026 in Review

GF Fund Management increased its Boston Scientific (BSX) stake by 1.1% in Q2 2026, buying an estimated $23.6K and bringing the position to 41,184 shares worth $1.76M. The position accounts for 0.02% of the portfolio, ranked #162.

GF Fund Management first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.05M in Q3 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

GF Fund Management held 41,184 shares of Boston Scientific worth $1.76M as of Q2 2026.
GF Fund Management bought 435 Boston Scientific shares in Q2 2026, an estimated $23.6K.
Boston Scientific made up 0.02% of GF Fund Management's portfolio in Q2 2026, its #162 holding.
GF Fund Management first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
GF Fund Management's Boston Scientific position peaked at $4.05M in Q3 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.